1 / 8

HITSC Implementation Workgroup

HITSC Implementation Workgroup. July 28, 2014. Quality Data Measurement Is An End-to-End Process. Electronic reporting MU, PQRS , AQC , etc. Documentation & extraction. Transport. Validation and analysis. User access. Data management Report viewing Case tracking. RX Labs Vitals

Télécharger la présentation

HITSC Implementation Workgroup

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HITSC Implementation Workgroup July 28, 2014

  2. Quality Data Measurement Is An End-to-End Process • Electronic reporting • MU, PQRS, AQC, etc Documentation & extraction Transport Validation and analysis User access • Data management • Report viewing • Case tracking RX Labs Vitals Problems Patient Provider Payer etc HIE Web services TCPIP SFTP Other Clinical source system • Data extraction • Queries • Pre-defined data marts • Management Info System • User information • Utilization analysis • Other Remediation and Improvement

  3. QDC Analytics Measure Inventory Government Commercial PCMH MU Stage 1 and 2 EP and EH PQRS Pioneer ACO

  4. Customer Examples

  5. Data Sources Clinical Claims

  6. CCDA has been workable, but it is cumbersome • From a technical perspective, it’s an unwieldy container, but these issues can be overcome • CCDA architecture provides framework for standardized document-representation structured data • Biggest issue is wide implementation variation across EHR vendors • Two types of variation • Data availability • One CCDA does not fit all needs • Some clinical information not available in CCDAs with certain vendors due to timing of CCDA generation in workflow • e.g, Labs and E&M codes not included in CCDAs that get generated at end of visits • Data introduced for MU Stage 2 CQMs not available or not standardized among vendors (e.g., patient communication codes, devices applied on patients, reasons for not performing intervention, etc) • Semantic normalization • Some fields are rough but often can be remediated (problems, medications, vitals, labs) vendor-by-vendor • Other fields are often not available or non-standardized across systems (historical procedure information, social history for codes on smoking status, cessation counseling, etc)

  7. Recommendations • Availability of standardized templates and implementation guides for high frequency and high value use cases • ambulatory visit, inpatient visit, ED visit, specialist referral, nursing home TOC, HIE data aggregation, quality data aggregation, etc • Current work in CCDA templates and FHIR profiles is working on this, but needs to be aggressively accelerated and made available • Certification testing focused more specifically on implementation of CCDA to support data availability and semantic normalization for high priority use cases

  8. Informationwww.maehc.orgMicky Tripathi, PhD MPPPresident & CEOmtripathi@maehc.org781-434-7906

More Related